Timothy P. Lynch is Director at BIOFORM MEDICAL INC (BFRM). They have made 2 open-market trades across 2 companies since 2009, most recently 2026-08-19.
CIK 0001270925
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $243K since 2026, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AEON | 6,500,000 | $1.6M |
| ARDM | 240,000 | $92K |
| BFRM | 45,454 | — |
| NABI | 3,846 | — |
| Total | $1.6M |
Shares reported on the most recent Form 4, priced at the 2026-08-21 close. 2 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.